DGAP-Adhoc: Heidelberg Pharma AG Announces Adjustment of Guidance
Heidelberg Pharma AG
WKN: A11QVV / Name: Heidelberg Pharma / Aktie / Biotechnologie & medizinische Forschung / Micro Cap /
2,50 €
-0,40 %
DGAP-Adhoc: Heidelberg Pharma AG Announces Adjustment of Guidance
DGAP-Adhoc: Heidelberg Pharma AG Announces Adjustment of Guidance
Heidelberg Pharma AG's “Adjustment of Guidance” announcement refers to a change in the company's financial outlook. The headline appears in Heidelberg Pharma's archive for multiple years, so the date is important when interpreting it.
The clearest matching ad-hoc announcement is dated October 4, 2022. The company raised its 2022 sales and other income forecast to €18.5–20.5 million, compared with €7.5–9.5 million previously. At the same time, it lowered expected operating expenses to €35–39 million and narrowed the expected EBIT loss to €16–20 million, versus €32.5–36.5 million previously
https://allyspin-german.com/
https://allyspin-german.com/
Neueste Beiträge
ramsaybolt5 in AirJoule Technologies: Short Squeeze Setup Amid Rising Risks, Kubota Corp. ADR